CSIMarket Company Name, Ticker, Industry, else..
Delcath Systems Inc   (NASDAQ: DCTH)
Other Ticker:  
 


 

Delcath Systems Inc

DCTH's Financial Statements and Analysis



Delcath Systems Inc reported in the third quarter of 2025 net earnings per share of $0.02 an improvement compare to net loss per share of $-0.48 recorded a year ago and decline of -33.33 % from $0.03 earned in I. Quarter (Mar 31 2025).


third quarter of 2025
Earnings Per Share Revenues
$ 0.02 $  20 Mill
$+0.50     $+12M     +156.75 %



Delcath Systems Inc 's Revenue rose by 156.75 % in third quarter of 2025 (Sep 30 2025) year on year, to $20 million and advanced by 5.28 % sequentially.


Delcath Systems Inc is

More on DCTH's Income Statement



Delcath Systems Inc 's net income of $0.830 million in the third quarter of 2025 increased from net loss of $-13.741 million II. Quarter a year ago.

Sequentially net earnings fell by -22.36 % from net income of $1.069 million realized in previous quarter.

More on DCTH's Growth

Delcath Systems Inc Inventories
Inventories grew by 70.12 % to $11 million from II. Quarter a year ago, sequentially inventories rose by 50.66 %. DCTH's Cash flow In the third quarter of 2025 company's net cash flow was $29 million, capital expenditures fell by -0.101748.51%, to $-1 millions compare to same quarter a year ago

More on DCTH's Cash flow Statement


Delcath Systems Inc does not pay out common stock dividend.

In trailing twelve-month period Delcath Systems Inc earned $ 0.24 cash per share, on a free-cash flow basis 800.7 % of net earning per share.

Book value grew by 41.20 % sequentially to $2.87 per share, 8814.93% of net income per share in trailing twelve-month period were contributed to shareholder value.
Tangible Book value grew to $ 2.87 per share from $ 2.03.

Company issued 0.55 million shares or 1.38 % in Sep 30 2025.
Interest Coverage Ratio was 1.06. Debt Coverage Ratio was 3.81.

• More on DCTH's Dividends

 Market Capitalization (Millions) 358
 Shares Outstanding (Millions) 40
 Total Debt (Millions $) -
 Revenue (TTM) (Millions $) 65
 Net Income (TTM) (Millions $) 0
 Cash Flow (TTM) (Millions $) 27
 Capital Exp. (TTM) (Millions $) -1
 Dividend TTM ($) 0 $
 Dividend Yield TTM (%) -
 Employees (TTM) $ 44




Delcath Systems Inc does not pay out common stock dividend.

In trailing twelve-month period Delcath Systems Inc had $ 0.24 cash flow per share, on a free-cash flow basis 800.7 % of net earning per share.

Book value grew by 41.20 % sequentially to $2.87 per share, 8814.93% of net income per share in trailing twelve-month period were contributed to shareholder value.
Tangible Book value grew to $ 2.87 per share from $ 2.03.

Company issued 0.55 million shares or 1.38 % in Sep 30 2025.
Interest Coverage Ratio was 1.06. Debt Coverage Ratio was 3.81.

• More on DCTH's Balance Sheets

 Market Capitalization (Millions) 358
 Shares Outstanding (Millions) 40
 Total Debt (Millions $) -
 Revenue (TTM) (Millions $) 65
 Net Income (TTM) (Millions $) 0
 Cash Flow (TTM) (Millions $) 27
 Capital Exp. (TTM) (Millions $) -1
 Dividend TTM ($) 0 $
 Dividend Yield TTM (%) -
 Employees (TTM) $ 44
   


  News about Delcath Systems Inc Earnings

Delcath Systems Inc Sees Unprecedented Revenue Surge in Q2 2024 but Remains Unprofitable

Delcath Systems Inc Reports Strong Revenue Growth in Q2 2024, Focuses on Liver Cancer Treatment
QUEENSBURY, N.Y. ? Delcath Systems Inc (Nasdaq: DCTH), an interventional oncology company focused on the treatment of primary and metastatic liver cancers, announced its financial results and business highlights for the second quarter ended June 30, 2024. The company reported a very solid revenue improvement of 1468.889% year on year, reaching $7.77 million.
While most companies in the Medical Equipment and Supplies industry are facing obstacles with diminishing transactions and battling fading top-lines, Delcath Systems Inc stands out as a shining star in the second quarter of 2024. In comparison to the p...

Delcath Systems Inc. Reports a Shortfall of $-0.45 per Share in Latest Fiscal Report

Delcath Systems Inc: A Bearish Outlook on Recent Financials and Appointments
Delcath Systems Inc, a notable player in the interventional oncology industry, recently released its financial results for the first quarter of 2024, revealing a staggering 425.796% year-on-year improvement in revenue, amounting to $3.14 million. While this may seem impressive at first glance, a closer examination of the figures brings forth several concerns for investors.
Firstly, it is imperative to note that despite the significant increase in revenue, the company reported a loss of $-0.45 per share ? a considerable downturn from the previous quarter's shortfall of $-0.35 per share. This indicates that Delcath Systems Inc...

Evanescence of Losses at Delcath Systems Inc. Signals Positive Growth in Q4 Fiscal Period 2023

Delcath Systems, Inc., a renowned interventional oncology company focusing on the treatment of primary and metastatic liver cancers, recently announced Martha S. Rook as its new Chief Operating Officer (COO). This strategic appointment is expected to enhance Delcath's operations and drive further advancements in innovative liver cancer treatments.
Martha S. Rook brings a wealth of experience to Delcath Systems, with a strong background in the healthcare and pharmaceutical industries. With her impressive track record in leadership positions, including her most recent role as Vice President of Operations at a prominent oncology therapeutics company, Rook is well-equipped to improve operational efficiency, ...

Delcath Systems Inc Defies Industry Downturn, Achieves Impressive Revenue Growth in Q3 2023

Despite the disappointing quarterly results reported by Delcath Systems Inc for the period from July to September 202...

Delcath Systems Inc Displays Positive Performance in Q2 2023, Showing Financial Growth in Liver Cancer Treatment Business

Delcath Systems Inc, a medical technology company specializing in the treatment of liver cancer, recently reported its financial results for the period of April to June 30, 2023. The company showed signs of improvement compared to the previous year, with a decrease in loss per share and an increase in income per share.
In terms of earnings per share, Delcath Systems Inc reduced its loss from $1.18 per share in the same period last year to $0.58 per share. This is good news for investors as it indicates that the company is becoming more efficient and managing its finances better. Additionally, the company improved its income per share from -$0.77 to -$0.58, showing a positive trend in its financial perfor...

Delcath Systems Inc Reports Significant Deficit Reduction and Impressive Revenue Growth in Q1 2023, Continues Positive Momentum

Investors, get ready to rejoice! Delcath Systems Inc has delivered some impressive res...


Date modified: 2025-11-04T21:24:04+00:00




Help

About us

Terms of Use

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2025 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.